Mannkind MNKD
NASDAQ MNKD
$4.18 -0.05 (-1.18%)
As of: Nov 11, 2026 · 3:50 PM EST

Mannkind (MNKD) Return on Sales [ROS] (2009 - 2026)

Updated

Mannkind (MNKD) posted Return on Sales [ROS] of -0.32% for Q2 2026, down 7.24 percentage points from 6.92% a year earlier but up 1.53 percentage points from the prior quarter.

Analysis

Mannkind (MNKD) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Mannkind was 2.34%, down 19.82 percentage points year-over-year; for FY2025, it came in at 11.12%, down 14.31 percentage points from FY2024.

  • Annual Return on Sales [ROS] shows a five-year change of +84.67 percentage points (FY2020 to FY2025).
  • In prior years, Mannkind's Return on Sales [ROS] was 25.42% in FY2024 (+21.06 pp), 4.36% in FY2023 (+68.62 pp), -64.26% in FY2022 (-1.93 pp) and -62.33% in FY2021 (+11.22 pp).
  • Quarterly Return on Sales [ROS] has run from a low of -191.51% in Q4 2021 to a high of 34.51% in Q4 2024 over five years.
  • On a year-over-year basis, Return on Sales [ROS] has declined in each of the last three quarters, with an average year-over-year change of -7.20 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q1 2023, with a gain of 162.49 percentage points; the weakest was Q1 2022, with a drop of 141.74 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -1.85% (Q1 2026), -6.87% (Q4 2025) and 23.01% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Mannkind 1.36 Bn 844.58 Mn 90.66 Mn -2.14%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -2.14%
Jun 30, 2026 -0.32%
Mar 31, 2026 -1.85%
Dec 31, 2025 -6.87%
Sep 30, 2025 23.01%
Jun 30, 2025 6.92%
Mar 31, 2025 28.45%
Dec 31, 2024 34.51%
Sep 30, 2024 18.21%
Jun 30, 2024 22.95%
Mar 31, 2024 25.24%
Dec 31, 2023 13.44%
Sep 30, 2023 9.94%
Jun 30, 2023 3.54%
Mar 31, 2023 -14.76%
Dec 31, 2022 -35.47%
Sep 30, 2022 -29.28%
Jun 30, 2022 -108.26%
Mar 31, 2022 -177.25%
Dec 31, 2021 -191.51%
API Access

Mannkind Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MNKD&period=max&api_key=YOUR_API_KEY